ArticleRespiratory research2019

Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer.

Xuexia Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.